Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2024 - 2030

Research Methodology

A three-pronged approach was followed for deducing the clinical trial supplies market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for clinical trial supplies market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of clinical trial supplies market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Clinical Trial Supplies Market Categorization:

The clinical trial supplies market was categorized into five segments, namely clinical phase (Phase I, Phase II, Phase III), product & service (Manufacturing, Storage & Distribution, Supply chain management), end-use (Pharmaceutical, Biologics, Medical device), therapeutic use (Oncology, CNS, Cardiovascular, Infectious disease, Metabolic disorders), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The clinical trial supplies market was segmented into clinical phase, product & service, end-use, therapeutic use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The clinical trial supplies market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; India; Japan; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa, Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Clinical trial supplies market companies & financials:

The clinical trial supplies market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• Almac Group is a contract development and manufacturing organization that specializes in providing integrated services, such as biomarker discovery, biomarker clinical trial management, companion diagnostic development, internal biomarker discovery, genomic services, proprietary discovery arrays, and bioinformatics consulting. It also offers physical, chemical, & analytical services, as well as clinical trial supply chain solutions such as manufacturing, packaging, labeling, binding, & distribution. Currently, Almac Clinical Services serves over 600 pharmaceutical and biotech firms globally, comprising 18 of the top 20 pharmaceutical companies. The company operates across 18 facilities, including Europe, the U.S., and Asia. It also has operations in the UK, Ireland, across the U.S., and in Asia (Singapore and Tokyo).

• Biocair is a private company that specializes in logistics & courier services for biotechnological, life science, and pharmaceutical industries. Products offered by the company are regulatory compliance, global logistics, value-added services, customer-focused solutions, and temperature-controlled solutions. These products are mainly utilized by commercial, clinical trial, & preclinical industries, as well as pharmaceutical professionals & scientists. It is a global specialist in clinical trial supply chain management, providing personalized logistics solutions for domestic and international multisite clinical trials. The company has a presence in Europe, the U.S., Africa, and Asia. Its global network operates 24/7 in over 160 countries, providing GDP-compliant life sciences supply chain management solutions.

• Catalent, Inc. is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell & gene therapies, and consumer health products. The company currently operates in four segments: Softgel & Oral Technologies, Biologics, Oral & Specialty Delivery, and Clinical Supply Services. The Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs & biologics in clinical trials. The company has more than 180 products launched annually, and around 700 products are under development. It has accomplished more than 5,000 clinical trials with 150,000 shipments a year to more than 80 countries. As of June 30, 2020, the firm had 53 manufacturing facilities, of which, 22 facilities are in the U.S.

• KLIFO is a Denmark-based company that provides consultancy services for clinical researchers, clinical trial supply, pharmacovigilance, regulatory affairs, and pharmaceutical & biotech products. Its services include feasibility & strategy studies, packaging, translation, labeling, preparation of protocols, and registration of pharmaceuticals. In addition, it offers database development, trial monitoring, clinical reports, and biostatistical analysis. The company completed 264 packaging campaigns and 2,200 shipments in 2019. The company operates in Denmark, Germany, Sweden, and the Netherlands.

• Movianto is part of the Walden Group, a European leader in logistics and transports for pharma. It provides services for pharmaceutical, biotech, medical device, and diagnostic industries. It provides outsourcing services along the supply chain, such as warehousing, transportation, active temperature control logistics, and other value-added services. The company has over 275,000 pallet locations spread over a network of 20 wholly owned warehouses in 11 European countries. It mainly operates in 3 regions in Europe: West (the UK and Eire), North (Belgium, the Netherlands, Germany, Switzerland, Denmark, the Czech Republic and Slovakia), and South (France, Spain).

• PCI Pharma Services, formerly known as Packaging Coordinators, Inc., provides clinical trial services, integrated pharmaceutical development, comprehensive commercial, and distribution services. In addition, it provides clinical packaging, primary packaging, clinical supplies management, and packaging design. These services are offered mainly to biotechnological and pharmaceutical industries. The company has operations in North America, Europe, and Asia Pacific.

• Sharp is a global leader in advanced clinical supply chain services and contract pharmaceutical packaging with over 32 clinical depots globally. The company develops, designs, and manufactures packaging machinery, printed, poly mail, stretch sleeves, stock, side & horizontal load bags, retail display, and thermal imprint ribbons. In addition, it offers auto-bagging machines, soft goods packaging, and inline thermal transfer printing systems. The company has operating facilities in the U.S., the UK, Belgium, and the Netherlands. Sharp is a part of UDG Healthcare plc, a company providing commercial, clinical, and packaging services to the healthcare industry.

• Thermo Fisher Scientific, Inc. provides analytical instruments, reagents & consumables, equipment, software, and services for manufacturing, analysis, research, and diagnostics under brands such as Thermo Scientific, Invitrogen, Unity Lab Services, Applied Biosystems, and Fisher Scientific. Thermo Scientific encompasses analytical instruments, lab equipment, and specialty diagnostics. Fisher Scientific offers enterprise solutions, instrument services, and provides parts & consumables in healthcare, safety, and science education. Applied Biosystems markets instruments and reagents for laboratory purposes. Invitrogen has products for genetic engineering, amplification, purification, quantification, and analysis. Thermo Fisher Scientific offers pharma services solutions for drug development, clinical trial logistics, and commercial manufacturing to customers through its Patheon brand. Patheon offers integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services, and commercial manufacturing & packaging.

• Marken is a fully owned subsidiary of UPS. The UPS Healthcare division employs 5,500 people in 128 sites across the world, including Polar Speed and Marken. For clinical drug product storage and distribution, the company provides GMP-compliant depot network and logistic hubs in 58 locations globally. It also offers biological sample shipments, Direct-to-Patient & home healthcare services, and biological kit manufacturing. It manages over 110,000 drug products and biological sample consignments monthly at all temperature ranges in around 220 countries. Additional services include storage, and distribution, supplementary material sourcing and GDP, regulatory, & compliance consulting.

• PAREXEL International Corporation offers services such as medical communications, clinical research, advanced technology products & services, consulting, and commercialization. These services are utilized by biotechnological, pharmaceutical, and medical device companies. The company operates in three segments: PAREXEL Consulting Services, PAREXEL Informatics, and Clinical Research Services. Services offered by the CRS segment include biostatistics, clinical trial management, observational studies, clinical logistics, and patient disease registries.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Clinical Trial Supplies Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Clinical Trial Supplies Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.